Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin and sitagliptin effects on beta-cell function in women with prior gestational diabetes
2008-003803-30Phase 2Completed
- Sponsor
- Azienda Ospedaliero-Universitaria Pisana
- Start
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of metformin and sitagliptin in gestational diabetes mellitus (GDM) (3 arms), sponsored by Azienda Ospedaliero-Universitaria Pisana. Primary endpoint: Beta-cell function. Started Feb 2011; status: completed.
02
Drugs
metforminsitagliptin
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on 2008-003803-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-003803-30.